Company News
Anthem Biosciences FY26 KPI Disclosure: Revenue Growth, Margins
• Anthem Biosciences discloses audited KPIs for FY26 showing ₹21.24 billion revenue and 15.17% YoY growth.
• Material margin improved to ₹13.12 billion with EBITDA margin at 41.01% and PAT margin at 2
